Ilika’s pilot line shift signals a licensing model in motion

Ilika Plc

Ilika’s Goliath pilot line is now fully commissioned and producing cells. This 1.5 MWh facility will manufacture 10 Ah solid state prototypes in the near term, with 50 Ah samples to follow. Both formats are aimed at demonstrating commercial viability to prospective partners across automotive, industrial and consumer sectors.

Production of the first 10 Ah units is expected by December, offering a near-term proof point. These will be used to support customer evaluation programmes, including performance benchmarking and integration testing. If results meet expectations, the 50 Ah format will move forward, with scaling supported through Ilika’s collaboration with an established battery industrialisation centre.

Many early-stage battery firms remain locked in R&D cycles or dependent on outsourced production. Ilika’s shift into controlled pilot output signals a more advanced stage of readiness. It strengthens its position in licensing negotiations and improves visibility for OEMs assessing integration paths.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Search

Search